22 May 2013
Keywords: pain, compound, deal, enhance, alza, biotech, developer
Article | 08 November 2004
Enhance Biotech, a developer of a portfolio of products focused on lifestyle drugs, says that its new merger partner Ardent ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 November 2004
15 November 2004
21 May 2013
© 2013 thepharmaletter.com